2 Australian states urge against under 40s taking AZ vaccine

The Queensland and Western Australia state governments have advised people under age 40 not to take the AstraZeneca coronavirus vaccine because of the risk of a rare blood clotting disorder, despite the Australian government making those shots available to all adults

Via AP news wire
Wednesday 30 June 2021 08:32
Virus Outbreak Australia
Virus Outbreak Australia

The Queensland and Western Australia state governments on Wednesday advised people under age 40 not to take the AstraZeneca vaccine because of the risk of a rare blood clotting disorder, despite the Australian government making those shots available to all adults.

The state governments’ advice to those under 40 is based on British government guidelines, while the new federal government’s position acknowledges the scarcity of the Pfizer vaccine and an urgent need to accelerate a slow national rollout.

The disagreement has stoked confusion as around half Australia’s population is locked down in Queensland, Western Australia, New South Wales and the Northern Territory due to new clusters, mostly of the delta variant, which is thought to be more contagious.

Australians have a choice of only two vaccines and locally manufactured AstraZeneca is more plentiful.

Queensland Chief Health Officer Jeannette Young said younger adults should wait for Pfizer to become available, despite only 5% of all Australians being fully vaccinated.

With only 42 coronavirus cases active in Queensland, AstraZeneca was not worth the risk for younger adults, she said.

“No, I do not want under 40s to get AstraZeneca because they are at increased risk of getting -- it is rare -- but they’re at increased risk of getting that rare clotting syndrome,” Young said.

“I don’t want an 18-year-old in Queensland dying from a clotting illness who, if they got COVID, probably wouldn’t die,” Young added.

Australia’s adviser on vaccines, Australian Technical Advisory Group on Immunization, known as ATAGI, recommends Pfizer for people under 60 because of the clotting risk.

AstraZeneca had been recommended for all adults until a 48-year-old Australian woman died from clotting in April. The vaccine was then recommended for people older than 50 until a 52-year-old died in May.

As concerns grew about new infections, the federal government on Monday decided to make AstraZeneca available to all adults and to indemnify against lawsuits doctors who administer it.

Western Australia Premier Mark McGowan said his government took a “different approach” to the federal government.

“Under 40s shouldn’t have it,” McGowan said, referring to AstraZeneca.

Health Minister Greg Hunt said the ATAGI advice continued to be his government’s “guiding light.”

But ATAGI advised that AstraZeneca could be administered to people under 60 “for whom Pfizer is not available.” Conditions included that benefits were likely to outweigh risks and that the decision to take AstraZeneca was informed.

“We deeply respect throughout the course of the pandemic there have been a range of views put forward, but the critical elements are that we have a national vaccine program, which is based on the medical advice and continues to be based on that medical advice,” Hunt said.

Hunt declined to say whether Australians younger than 40 should expect doctors would inject them with AstraZeneca.

“I certainly would never step between a patient and a doctor where an informed decision to be vaccinated was made,” Hunt said.

Many younger Australians have proved eager to accept the AstraZeneca option.

The central Australian city of Alice Springs on Wednesday was added to the list of places locked down.

A miner had been infected in a gold mine then spent several hours in the Alice Springs airport before flying home from the Northern Territory to South Australia, where he infected his wife and three of his children in the state capital Adelaide, officials said.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in